Ben Davidson research group

B. Davidson

The research group is focusing on the characterization of ovarian carcinoma cells in effusions, with comparative models of breast carcinoma and malignant mesothelioma.

We focus on:

Optimizing cancer diagnosis in effusions
Mapping events mediating invasion and metastasis
Studying genetic events and their clinical significance
Identifying pro-survival molecules

Research areas

PubMed registered articles (automatically updated)

Print this page [678 visits]

News & events

Untangling the development of breast cancer
Researchers announce the first comprehensive genome studies of the evolution of 21 breast cancers
May 18, 2012

Presentation of prestigious research project
Actionable Targets in Cancer Metastasis (MetAction) – from Bed to Bench to Byte to Bedside
May 16, 2012

GAP cancer conference in Oslo May 14-16
Global Academic Programs 2012
May 11, 2012

Trial lecture and disputation May 9th
Trevor Clancy
May 8, 2012

Study by Ane Hansen Kjenseth et al. featured on the cover of Journal of Biological Chemistry
May 7, 2012

More news

Latest publications

Ben Davidson

Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM
Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma
Clin Cancer Res (in press)
PubMed 22492981

Konstantinovsky S, Davidson B, Reich R
Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids
Clin Exp Metastasis (in press)
PubMed 22476538

Hetland TE, Holth A, Kærn J, Flørenes VA, Tropé CG, Davidson B (2012)
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases
Virchows Arch, 460 (5), 505-13
PubMed 22476403

More publications